Position in LLY
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$1,805,959,197
+$1,305,086,267 QoQ
Shares Held
1,963,490
+321.3% QoQ
Ownership
0.208%
of shares outstanding
% of Portfolio
4.66%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 29%
Shared 0%
None 71%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026FIFTH THIRD BANCORP holds $3,423,078,141 across 17 Drug Manufacturers - General names. LLY ranks #1 (52.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
1,963,490 | $1,805,959,197 | |
| 2 | JNJ |
Johnson & Johnson
|
1,969,767 | $481,489,845 | |
| 3 | ABBV |
AbbVie Inc.
|
2,197,894 | $478,019,966 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,543,397 | $185,655,225 | |
| 5 | AMGN |
Amgen Inc
|
461,207 | $162,275,682 | |
| 6 | PFE |
Pfizer Inc
|
4,536,233 | $127,377,422 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
668,661 | $93,191,283 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,191,379 | $72,257,136 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,805,959,197 | 1,963,490 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $500,872,930 | 466,067 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $353,713,066 | 463,582 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $360,593,428 | 462,578 | Shares | Defined | 2025-07-15 | |
| 2025-03-31 | $372,624,988 | 451,169 | Shares | Defined | 2025-04-15 | |
| 2024-12-31 | $344,051,064 | 445,662 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $401,187,297 | 452,838 | Shares | Defined | 2024-10-17 | |
| 2024-06-30 | $403,095,094 | 445,222 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $321,739,361 | 413,568 | Shares | Defined | 2024-04-23 | |
| 2023-12-31 | $228,630,550 | 392,216 | Shares | Defined | 2024-01-19 | |
| 2023-09-30 | $196,978,462 | 366,724 | Shares | Defined | 2023-10-31 | |
| 2023-06-30 | $171,852,093 | 366,438 | Shares | Defined | 2023-07-26 | |
| 2023-03-31 | $82,545,804 | 240,364 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $79,540,932 | 217,420 | Shares | Defined | 2023-01-25 | |
| 2022-09-30 | $65,379,429 | 202,194 | Shares | Defined | 2022-10-25 | |
| 2022-06-30 | $64,368,084 | 198,526 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $51,066,071 | 178,322 | Shares | Defined | 2022-04-19 | |
| 2021-12-31 | $45,664,414 | 165,319 | Shares | Defined | 2022-02-01 | |
| 2021-09-30 | $34,742,757 | 150,369 | Shares | Defined | 2021-10-15 | |
| 2021-06-30 | $34,532,661 | 150,456 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $28,141,257 | 150,633 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $25,454,149 | 150,759 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $24,644,293 | 166,493 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $24,861,777 | 151,430 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $16,954,635 | 122,222 | Shares | Defined | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||